ARMANDO RODRIGUEZ: Open Payments
NPI 1306317284 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 13 payments from 5 companies in 2025. Trend: 2023 $572 · 2024 $189 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Amgen Inc. | 1 | $23 |
| Vifor Pharma, Inc. | 1 | $17 |
Products named: Kerendia, CAPLYTA, FARXIGA, KRYSTEXXA, Veltassa.
Industry payments across TX — which companies pay providers there.
